Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer

Oncogene

Volumn 25, Issue 20, 2006, Pages 2953-2960

  Leiblich, A ^a   Cross, S S ^a   Catto, J W F ^a   Phillips, J T ^a   Leung, H Y ^b   Hamdy, F C ^a   Rehman, I ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Benign prostatic hyperplasia; Hypermethylation; Metastatic; Prostate cancer; Proteomic

Indexed keywords

AZACITIDINE; BISULFITE; LACTATE DEHYDROGENASE;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN BHP45; CELL STRAIN CWR22; CELL STRAIN DU145; CELL STRAIN LNCAP; CELL STRAIN LNCAP LN3; CELL STRAIN PC3; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME KINETICS; GENE SILENCING; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STATISTICAL ANALYSIS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; ZYMOGRAPHY;

AMINO ACID SEQUENCE; AZACITIDINE; BASE SEQUENCE; BONE NEOPLASMS; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA, NEOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; ISOENZYMES; L-LACTATE DEHYDROGENASE; MALE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; PROTEOMICS; TUMOR CELLS, CULTURED;

EID: 33646690509     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209262     Document Type: Article

References (45)

1. Ahram M, Best CJ, Flaig MJ, Gillespie JW, Leiva IM, Chuaqui RF et al. (2002). Mol Carcinog 33: 9-15.
2. Allen S, Heath PR, Kirby J, Wharton SB, Cookson MR, Menzies FM et al. (2003). J Biol Chem 278: 6371-6383.
3. Banks RE, Dunn MJ, Hochstrasser DF, Sanchez JC, Blackstock W, Pappin DJ et al. (2000). Lancet 356: 1749-1756.
4. Bergmeyer HU (ed). (1974). Methods of Enzymatic Analysis. Academic press: New York, pp 574-578.
5. Bhandari MS, Petrylak DP, Hussain M. (2005). Eur J Cancer 41: 941-953.
6. Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW et al. (2001). Int J Radiat Oncol Biol Phys 51: 349-353.
7. Cheung PK, Woolcock B, Adomat H, Sutcliffe M, Bainbridge TC, Jones EC et al. (2004). Cancer Res 64: 5929-5933.
8. Chodak GW, Thisted RA, Gerber GS, Johansson JE, Adolfsson J, Jones GW et al. (1994). N Engl J Med 330: 242-248.
9. Chu LW, Pettaway CA, Liang JC. (2001). Cancer Genet Cytogenet 127: 161-167.
10. Das PM, Singal R. (2004). J Clin Oncol 15: 4632-4642.
11. Ding SJ, Li Y, Shao XX, Zhou H, Zeng R, Tang ZY et al. (2004). Proteomics 4: 982-994.
12. Firth JD, Ebert BL, Ratcliffe PJ. (1995). J Biol Chem 270: 21021-21027.
13. Graves PR, Haystead TA. (2002). Microbiol Mol Biol Rev 66: 39-63.
14. Grayhack JT, Lee C, Oliver L, Schaeffer AJ, Wendel EF. (1980). Prostate 1: 227-237.
15. Greenlee RT, Murray T, Bolden S, Wingo PA. (2000). CA Cancer J Clin 50: 7-33.
16. Gronberg H. (2003). Lancet 36: 859-864.
17. Hamdy FC. (2001). Cancer Treat Rev 27: 143-151.
18. Himpel S, Panzer P, Eirmbter K, Czajkowska H, Sayed M, Packman LC et al. (2001). Biochem J 359: 497-505.
19. Holbrook JJ, Liljas A, Steindel SJ, Rossman MG. (1975). In: The Enzymes. Boyer PD (ed). Lactate Dehydrogenase. Academic Press: New York, pp 191-292.
20. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L et al. (1980). Prog Clin Biol Res 37: 115-132.
21. Klingler HC, Bretland AJ, Reid SV, Chapple CR, Eaton CL. (1999). Prostate 41: 110-120.
22. Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL. (2005). Neoplasia 7: 1-6.
23. Li LC, Carroll PR, Dahiya R. (2005). J Natl Cancer Inst 97: 103-115.
24. Liu X, Wu Y, Zehner ZE, Jackson-Cook C, Ware JL. (2003). Electrophoresis 24: 3445-3453.
25. Maekawa M, Taniguchi T, Ishikawa J, Sugimura H, Sugano K, Kanno T. (2003). Clin Chem 49: 1518-1520.
26. Markert CL, Shaklee JB, Whitt GS. (1975). Science 189: 102-114.
27. Martinez-Zaguilan R, Seftor EA, Seftor RE, Chu YW, Gillies RJ, Hendrix MJ. (1996). Clin Exp Metast 14: 176-186.
28. Meehan KL, Holland JW, Dawkins HJ. (2002). Prostate 50: 54-63.
29. Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ et al. (1996). Clin Cancer Res 2: 1627-1636.
30. Rehman I, Azzouzi AR, Catto JW, Allen S, Cross SS, Feeley K et al. (2004a). Urology 64: 1238-1243.
31. Rehman I, Azzouzi AR, Cross SS, Deloulme JC, Catto JW, Wylde N et al. (2004b). Hum Pathol 35: 1385-1391.
32. Rehman I, Cross SS, Catto JW, Leiblich A, Mukherjee A, Rahmene AR et al. (2005). Prostate 65: 322-330.
33. Rehman I, Takata M, Wu YY, Rees JL. (1996). Oncogene 12: 2483-2490.
34. Rethore MO, Junien C, Malpuech G, Baccichetti C, Tenconi R, Kaplan JC et al. (1976). Ann Genet 19: 140-142.
35. Salplachta J, Necas J. (2000). Acta Vet Brno 69: 267-275.
36. Schulz WA, Burchardt M, Cronauer MV. (2003). Mol Hum Reprod 9: 437-448.
37. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P et al. (1996). J Biol Chem 271: 32529-32537.
38. Shi Q, Le X, Wang B, Abbruzzese JL, Xiong Q, He Y et al. (2001). Oncogene 20: 3751-3756.
39. Shim H, Dolde C, Lewis BC, Wu CS, Dang G, Jungmann RA et al. (1997). Proc Natl Acad Sci USA 94: 6658-6663.
40. Stern R, Shuster S, Neudecker BA, Formby B. (2002). Exp Cell Res 276: 24-31.
41. Takeno T, Li SS. (1989). Biochem J 257: 921-924.
42. Tsoi SC, Zheng J, Xu F, Kay HH. (2001). Placenta 22: 317-322.
43. Vaupel P, Harrison L. (2004). Oncologist 9: 4-9.
44. Walenta S, Mueller-Klieser WF. (2004). Semin Radiat Oncol 14: 267-274.
45. Walenta S, Schroeder T, Mueller-Klieser W. (2004). Curr Med Chem 11: 2195-2204.